Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial

2020186 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet. Gastroenterology & hepatology

Volume 6, Issue 2, pp. 128-138

Field-Weighted Citation Impact: 7.71